1.135USD-7.69%Mkt Cap: 1.30M USDP/E: 0.00Last update: 2026-06-01
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The compa…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.30M USD
Enterprise Value10.33M USD
Revenue (TTM)735.20K USD
Gross Profit632.91K USD
Net Income (TTM)-14.03M USD
Revenue/Share2.201 USD
Last Price1.135 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-1.41
PEG—
EV/EBITDA-1.53
EV/Revenue14.05
P/S1.87
P/B0.28
EPS (TTM)1377.40
EPS (Forward)-0.85
52W Range
0.91000% of range382.50
52W High382.50 USD
52W Low0.9100 USD
Profitability
Gross Margin77.62%
Oper. Margin-9748.80%
EBITDA Margin0.00%
Profit Margin-1720.98%
ROE-89.00%
ROA-56.29%
Growth
Revenue Growth-78.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.68M USD
CapEx (TTM)—
FCF Margin-861.10%
FCF Yield-486.52%
Net Debt-3.43M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.00
Current Ratio1.41
Quick Ratio1.23
Book Value/Sh4.263 USD
Cash/Share0.3240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.15M
Float10.46M
Insiders0.61%
Institutions0.20%
Short Interest
Short Ratio0.0d
Short % Float0.49%
Short % Out.0.49%
Shares Short5.64K
Short (prev mo.)22.89K
Technical
SMA 5010.27 (-88.9%)
SMA 20087.43 (-98.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)1.28M
Avg Vol (10d)2.57M
Technical Indicators
RSI (14)23.7
MACD-2.5934
MACD Signal-2.9722
MACD Hist.+0.3788
BB Upper6.742 USD
BB Middle3.133 USD
BB Lower-0.4747 USD
BB Width230.30%
ATR (14)1.151 USD
Vol Ratio (20d)0.45x